LEROCHOL
Launchlerodalcibep-liga
BLAINJECTIONINJECTABLE
Approved
Dec 2025
Lifecycle
Launch
Competitive Pressure
30/100
Data completeness
2/8 — Basic
LEROCHOL (lerodalcibep-liga) is lerodalcibep-liga is a recombinant fusion protein that binds pcsk9 with picomolar affinity. First approved in 2025.
Drug data last refreshed 10h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LEROCHOL (lerodalcibep-liga) is a recombinant fusion protein PCSK9 inhibitor administered by injection. It binds PCSK9 with picomolar affinity to prevent degradation of LDL receptors on hepatocytes, thereby lowering LDL-C levels in the blood. The drug is indicated for hypercholesterolemia management in patients requiring additional LDL-C reduction.
Growth
Recently launched injectable biologic in a competitive lipid-management market; expect moderate-sized commercial teams focused on clinical adoption and payer access.
Mechanism of Action
Lerodalcibep-liga is a recombinant fusion protein that binds PCSK9 with picomolar affinity. PCSK9 binds to low-density lipoprotein receptor (LDLR) on the surface of hepatocytes to promote LDLR degradation within the liver. By inhibiting the binding of PCSK9 to LDLR, lerodalcibep-liga increases the…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
LEROCHOL launch roles focus on driving adoption in competitive cardiology/lipid management space. Career growth depends on execution against established PCSK9 competitors and payer negotiation success.
Brand Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.